Warren, NJ, United States of America

Yu-Sheng Chao

USPTO Granted Patents = 31 


 

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 169(Granted Patents)


Location History:

  • Taipei, TW (2009 - 2010)
  • Warren, NJ (US) (2008 - 2012)
  • Monmouth Junction, NJ (US) (2011 - 2015)
  • New York, NY (US) (2014 - 2018)
  • New Taipei, TW (2022)

Company Filing History:


Years Active: 2008-2022

Loading Chart...
Loading Chart...
Loading Chart...
31 patents (USPTO):

Title: Yu-Sheng Chao: Innovator in Protein Kinase Inhibitors and Hematopoietic Stem Cell Mobilization

Introduction

Yu-Sheng Chao, based in Warren, NJ, is a prolific inventor with a remarkable portfolio, holding 31 patents to date. His work extensively revolves around the fields of medicinal chemistry and cancer treatment, emphasizing the development of innovative therapeutic compounds.

Latest Patents

Among his latest innovations are notable patents that focus on thiazole compounds and heterocyclic compounds. The first patent, titled "Thiazole Compounds as Protein Kinase Inhibitors," introduces thiazole compounds of a specific formula alongside pharmaceutical compositions. These compounds exhibit the potential to inhibit tyrosine kinases, presenting a novel approach to treating cancers associated with these enzymes.

The second patent, "Heterocyclic Compounds and Use Thereof," outlines various heterocyclic compounds. This patent discusses their role in mobilizing hematopoietic stem cells and endothelial progenitor cells into peripheral circulation. Additionally, it provides methods for treating tissue injury, inflammatory diseases, and autoimmune diseases using these innovative compounds.

Career Highlights

Yu-Sheng Chao has made significant contributions to the field through his employment with reputable organizations such as the National Health Research Institutes and International Chlorella Co., Ltd. His work has consistently demonstrated a commitment to advancing medical research and therapeutic development.

Collaborations

Throughout his career, Chao has collaborated with distinguished colleagues, including Hsing-Pang Hsieh and Tsu-An Hsu. These partnerships have enriched his research and fostered innovative approaches to drug development.

Conclusion

Yu-Sheng Chao stands out as a leading inventor in the realm of pharmacology, specifically in the development of compounds to address critical health issues, including cancer and other diseases. His extensive patent portfolio reflects his dedication to innovation and the advancement of therapeutic science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…